Sg3 Management, LLC Igm Biosciences, Inc. Call Options Transaction History

Sg3 Management, LLC

3 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2021 Feb 15, 2022	SELL	$27.59 - $66.39 $1.27 Million - $3.05 Million	-46,000 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$65.76 - $90.65 $263,040 - $362,600	-4,000 Reduced 8.0%	46,000 $3.03 Million
Q3 2020 Nov 13, 2020	BUY	$43.0 - $84.01 $2.15 Million - $4.2 Million	50,000 New	50,000 $3.69 Million

20.7M

68K

52.2K

Ticker IGMS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,969,000
Market Cap $302M
Description
IGM Biosciences, Inc., a biotechnology company, develops Immunoglobulin M (IgM) antibodies for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. The company's lead product candidate is IGM-2323, a bispecific IgM antibody that is in Phase 2 clinical trials to treat patients with relapsed/refractory B cell Non...

Get notified when there are updates to the investment portfolio of Sg3 Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sg3 Management, LLC with notifications on news.